Global Biosimilar Market to Grow at a CAGR of 25.0% from 2017 to 2025 According to Latest Research
This report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market
(EMAILWIRE.COM, August 05, 2018 ) The Global Biosimilar Market is Valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of 25.0% during 2018-2025.
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
Access this report at: https://www.themarketreports.com/report/global-biosimilar-market-research-report-2018
Companies profiled in this report are Allergan Plc, Biocad, Biocon, Bioxpress Therapeutics Sa, Boehringer Ingelheim Gmbh, Celltrion Inc., Coherus Biosciences, Inc, Dr. Reddy’s Laboratories Ltd., Genor Biopharma Co. Ltd, Intas Pharmaceuticals Limited, Novartis Ag, Pfizer, Inc., Reliance Life Sciences and more.
Analysis by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into
• Human Growth Hormones
• Monoclonal Antibodies
• Insulin
• Peptides
• Erythropoietin
• Others
Analysis by Applications, this report focuses on consumption, market share and growth rate of Biosimilar in each application, can be divided into
• Oncology
• Chronic and Autoimmune Diseases
• Growth Hormone Deficiency
• Infectious Diseases
• Others
Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/867622
Table of Contents:
1 Biosimilar Market Overview
2 Global Biosimilar Market Competition by Manufacturers
3 Global Biosimilar Capacity, Production, Revenue by Regions
4 Global Biosimilar Supply (Production), Consumption, Export, Import by Regions
5 Global Biosimilar Output, Revenue, Price Trend by Types
6 Global Biosimilar Market Analysis by Applications
7 Global Biosimilars Manufacturers Profiles/Analysis
8 Biosimilar Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Biosimilar Market Forecast
13 Research Findings and Conclusion
14 Methodology and Data Source
Inquire more about this report at: https://www.themarketreports.com/report/ask-your-query/867622
The Market Reports
We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
Website: https://www.themarketreports.com/
Write us at sales@themarketreports.com
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
Access this report at: https://www.themarketreports.com/report/global-biosimilar-market-research-report-2018
Companies profiled in this report are Allergan Plc, Biocad, Biocon, Bioxpress Therapeutics Sa, Boehringer Ingelheim Gmbh, Celltrion Inc., Coherus Biosciences, Inc, Dr. Reddy’s Laboratories Ltd., Genor Biopharma Co. Ltd, Intas Pharmaceuticals Limited, Novartis Ag, Pfizer, Inc., Reliance Life Sciences and more.
Analysis by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into
• Human Growth Hormones
• Monoclonal Antibodies
• Insulin
• Peptides
• Erythropoietin
• Others
Analysis by Applications, this report focuses on consumption, market share and growth rate of Biosimilar in each application, can be divided into
• Oncology
• Chronic and Autoimmune Diseases
• Growth Hormone Deficiency
• Infectious Diseases
• Others
Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/867622
Table of Contents:
1 Biosimilar Market Overview
2 Global Biosimilar Market Competition by Manufacturers
3 Global Biosimilar Capacity, Production, Revenue by Regions
4 Global Biosimilar Supply (Production), Consumption, Export, Import by Regions
5 Global Biosimilar Output, Revenue, Price Trend by Types
6 Global Biosimilar Market Analysis by Applications
7 Global Biosimilars Manufacturers Profiles/Analysis
8 Biosimilar Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Biosimilar Market Forecast
13 Research Findings and Conclusion
14 Methodology and Data Source
Inquire more about this report at: https://www.themarketreports.com/report/ask-your-query/867622
The Market Reports
We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
Website: https://www.themarketreports.com/
Write us at sales@themarketreports.com
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results